Private company

Old Ayala, Inc

Old Ayala, Inc is an American biological products company, incorporated in Delaware.1 It is headquartered in Wilmington, Delaware.1

Last updated Oct 20, 2026.

Overview

  • IndustryBiological Products, (No Diagnostic Substances)1
  • HeadquartersWilmington, Delaware1
  • Incorporated inDE2
  • Business address1313 N. Market Street, Suite 5100, Wilmington, De 198012
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

13.0%Gross margin3
-5419.5%Operating margin3
-5493.2%Net margin3
-80.3%Revenue growth, 20223
-$34.5MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue2¢$602.0K
  • Research and development96¢$27.9M
  • Income tax2¢$584.0K

Out of $692.0K in revenue.3 The company lost money this year.

Financial statements

Revenue453$692.0K in 2022−70% since 2019
0$1.0M$2.0M$3.0M$4.0M2019: $2.3M$2.3M20192020: $3.7M$3.7M2020+59%2021: $3.5M$3.5M2021−5%2022: $692.0K$692.0K2022−80%
Gross profit43$90.0K in 2022−91% since 2019
0$500.0K$1.0M$1.5M2019: $1.0M$1.0M20192020: $0$020202022: $90.0K$90.0K2022
Operating income453-$37.5M in 2022+112% since 2019
-$40.0M-$30.0M-$20.0M-$10.0M02019: -$17.7M-$17.7M20192020: -$29.8M-$29.8M2020+68%2021: -$39.2M-$39.2M2021+32%2022: -$37.5M-$37.5M2022−4%
Net income453-$38.0M in 2022+114% since 2019
-$60.0M-$40.0M-$20.0M02019: -$17.8M-$17.8M20192020: -$30.1M-$30.1M2020+69%2021: -$40.3M-$40.3M2021+34%2022: -$38.0M-$38.0M2022−6%
Fiscal year20182019202020212022
Revenue$2.3M4$3.7M5$3.5M3$692.0K3
Cost of revenue$1.3M4$3.7M5$3.5M3$602.0K3
Gross profit$1.0M4$04$90.0K3
Research and development$4.3M4$14.4M4$22.4M5$29.9M3$27.9M3
Operating expenses$300.0K5
Operating income-$17.7M4-$29.8M5-$39.2M3-$37.5M3
Income before tax-$39.5M3-$37.4M3
Income tax$306.0K4$425.0K5$776.0K3$584.0K3
Net income-$17.8M4-$30.1M5-$40.3M3-$38.0M3
Earnings per share-$2.803-$2.463
Earnings per share (diluted)-$2.803-$2.463
Shares (weighted, basic)14.4M shares315.4M shares3
Shares (weighted, diluted)14.4M shares315.4M shares3

Compare Old Ayala, Inc with another company

Corporate structure

Old Ayala, Inc sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Old Ayala, Inc

  • Redmile Group, LLC Filed SC 13G/A on Old Ayala, Inc, latest Feb 8, 2023 (2 filings since Feb 14, 2022)
  • Harel Insurance Investments & Financial Services Ltd. Filed SC 13G on Old Ayala, Inc, latest Feb 7, 2023 (2 filings since Jan 31, 2022)
  • Wellington Management Company Filed SC 13G/A on Old Ayala, Inc, latest Feb 6, 2023 (2 filings since Feb 4, 2022)
  • Yair Chaim Schindel Filed SC 13G/A on Old Ayala, Inc, latest Jan 23, 2023 (3 filings since Jan 24, 2022)
  • Novartis Institutes for BioMedical Research, Inc. Filed SC 13G/A on Old Ayala, Inc, latest Oct 31, 2022
  • Old Ayala, Inc Wilmington, Delaware

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Old Ayala, Inc reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$1.6M3 Dec 31, 2022$1.6M3 Dec 31, 2021+0.1%
Accumulated depreciation$660.0K3 Dec 31, 2022$498.0K3 Dec 31, 2021+32.5%
Property and equipment, net$960.0K3 Dec 31, 2022$1.1M3 Dec 31, 2021−14.3%
Operating-lease assets (leased space)$1.5M3 Dec 31, 2022

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$2.4M3 Dec 31, 2022$37.0M3 Dec 31, 2021−93.5%

Leadership

Who has led Old Ayala, Inc, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Roni Mamluk2020–2023

President

  1. Roni Mamluk2020–2023

Chief financial officer

  1. Maimon Yossi2020–2023
  2. Roy Golan2023
2025
Board members and other officers (10)

Former names

  • Ayala Pharmaceuticals, Inc.Jan 8, 2020 to Jan 19, 20232

Timeline

  1. Jan 25, 20238-K Completed an acquisition or sale; Listing notice or transfer; Change to shareholders' rights22
  2. Jan 13, 20238-K Shareholder vote23
  3. Jan 4, 20238-K Other events24
  4. Nov 23, 20228-K Listing notice or transfer25
  5. Nov 17, 20228-K Listing notice or transfer26
  6. Oct 19, 20228-K Entered a material agreement; Executive or director change; Regulation FD disclosure27
  7. Sep 12, 20228-K Other events28
  8. Jul 5, 20228-K Other events29
  9. Jun 14, 20228-K Shareholder vote30
  10. Jun 3, 20228-K Ended a material agreement31
  11. May 7, 2020New chief executive Roni Mamluk becomes CEO9

Filings

62 filings to the SEC since October 2021: 2 annual reports, 4 quarterly reports, 10 major events, 21 insider forms, 10 large holders, 15 other. The latest 20:

  1. Nov 1, 20233 EDGAR
  2. Nov 1, 20233 EDGAR
  3. Oct 31, 20233 EDGAR
  4. Mar 31, 202310-K ANNUAL REPORT EDGAR
  5. Feb 8, 2023SC 13G/A EDGAR
  6. Feb 7, 2023SC 13G EDGAR
  7. Feb 6, 2023SC 13G/A SEC SCHEDULE 13G EDGAR
  8. Jan 30, 202315-12G EDGAR
  9. Jan 25, 20238-K EDGAR
  10. Jan 24, 20234 EDGAR
  11. Jan 23, 2023EFFECT EDGAR
  12. Jan 23, 2023EFFECT EDGAR
  13. Jan 23, 20234 OWNERSHIP DOCUMENT EDGAR
  14. Jan 23, 20234 OWNERSHIP DOCUMENT EDGAR
  15. Jan 23, 20234 OWNERSHIP DOCUMENT EDGAR
  16. Jan 23, 20234 OWNERSHIP DOCUMENT EDGAR
  17. Jan 23, 20234 OWNERSHIP DOCUMENT EDGAR
  18. Jan 23, 20234 OWNERSHIP DOCUMENT EDGAR
  19. Jan 23, 20234 OWNERSHIP DOCUMENT EDGAR
  20. Jan 23, 2023SC 13G/A EDGAR

The 62 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Old Ayala, Inc is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGAROld Ayala, Inc1
  • CIK0001797336
  • Employer ID (EIN)82-35783751
  • Filer statusNon-accelerated filer<br>smaller reporting company<br>emerging growth company1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2836 Biological Products, (No Diagnostic Substances)1
  • Business address1313 N. Market Street, Suite 5100, Wilmington, DE 198011
  • Phone(857) 444-05531
  • Shares outstanding1 as of Mar 30, 20233
  • Public float$37.4M as of Jun 30, 20223
  • On EDGAR sinceJan 8, 20201
  • Filings142 in all: 4 (37), 8-K (17), 3 (14), SC 13G/A (10), 10-Q (9), SC 13G (7), CORRESP (6), EFFECT (5)1
    All 31 form types

    UPLOAD (4), 10-K (3), 425 (3), DEF 14A (2), DEFA14A (2), DRSLTR (2), POS AM (2), S-1 (2), S-1/A (2), S-3 (2), 15-12G (1), 25-NSE (1), 4/A (1), 424B4 (1), 8-A12B (1), CERT (1), DEFM14A (1), DRS (1), DRS/A (1), RW (1), S-1MEF (1), S-8 (1), S-8 POS (1)

  • Latest filingsAnnual report (10-K) Mar 31, 2023
    Quarterly report (10-Q) Nov 3, 2022
    Proxy statement (DEF 14A) Apr 27, 2022
    Latest 8-K (8-K) Jan 25, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
    SEC EDGAROther events
  25. 25
  26. 26
  27. 27
  28. 28
    SEC EDGAROther events
  29. 29
    SEC EDGAROther events
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36